Table 3.

Candidate SNP markers associated with the MGT phenotype.

Marker	Chromosome	Position	Gene	Variant	Allele (M > m)	MAF (Cases)	MAF (Control)	OR (95% CI)	P-value†	P-value‡	P-value§
BICF2S23741980	7	25,743,449	TNFSF18	Exon	A > T	0.024	0.273	0.00(0.00–0.30)	0.005	0.003	0.00009
BICF2S23750600	17	56,103,488	WDR3	Promoter	T > C	0.048	0.318	0.01(0.00–0.31)	0.006	0.003	0.0001
BICF2G63086613	7	78,537,371	SEH1L	Exon	C > A	0.262	0.773	0.11(0.02–0.50)	0.0002	0.002	0.0002
BICF2S23447362	25	40,378,887	MFF	Exon	C > T	0.143	0.682	0.12(0.03–0.54)	0.00004	0.001	0.0003
BICF2G630519109	14	4,790,093	PLXNA4	Exon	T > C	0.405	0.773	0.05(0.00–0.51)	0.008	0.004	0.0005

SNP, single-nucleotide polymorphism; MGT, mammary gland tumor; M > m, major allele to minor allele; MAF, minor allele frequency; OR, odds ratio; CI, confidence interval. ^†Alleles; ^‡Genotype; ^§Linear regression. (Genome-wide significance level: α′ = 3.94×10⁻⁷).